Delivery Order SPE2DB22D1017-SPE2DB24FE8UV
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,336.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,296,828 units of Doxepin HCL 3 mg tablets. This fixed-price delivery order has an ultimate completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department...
- This federal contract award is for the delivery of 3mg doxepin hydrochloride tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,057.62 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $5,035.90 from the Defense Logistics Agency to supply 4563118089 Doxepin HCl 3 mg tablets, 30 count, by December 18, 2023. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to the agency's location in Conshohocken, Pennsylvania in support of DLA Troop Support Medical facilities and programs. No set-aside designation was applied to this award issued against an existing indefinite...
- The Defense Logistics Agency awarded a $1,516.89 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 3 mg doxepin hydrochloride. The prime contractor will deliver the pharmaceutical products to its facility located in Conshohocken, Pennsylvania by July 12, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order for prescription drugs supports the Agency's mission to provide...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price ceiling value of $2,490.76 and a completion date of July 7, 2025. The award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, to provide a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price structure with a ceiling value of $94,108.05 and a performance period through May 6, 2025. The contract is for the supply of pharmaceutical products and medical supplies, including medications across various therapeutic domains such as diabetes treatments, neurological medications,...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $3,376.40 and an ultimate completion date of July 2, 2025. It was awarded by the Defense Logistics Agency (DLA), which is the Department of Defense's combat logistics support agency. The contract provides for the supply of a range of pharmaceutical products and medical supplies to support military healthcare...
- The U.S. Department of Defense (DoD) has awarded a delivery order contract worth $26,769.42 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, which enables the DLA to efficiently procure a range of pharmaceutical products and medical supplies for military treatment programs and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,355.40 and a performance period through May 2, 2025. It is a firm fixed price contract for the delivery of pharmaceutical and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is...
- This $3,214.74 firm-fixed price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides a range of prescription medications, over-the-counter drugs, and medical supplies to support the Department of Defense's (DoD) healthcare programs and facilities. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE8UVDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Doxepin Hydrochloride 3 mg tablets. The contract has a ceiling value of $2,744.99 and an ultimate completion date of November 28, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is an individual award under that broader IDC. In addition, AmerisourceBergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/27/23 |